Literature DB >> 9687094

Morphine's immunoregulatory actions are not shared by fentanyl.

T V Bilfinger1, C Fimiani, G B Stefano.   

Abstract

Fentanyl is a commonly used narcotic agent in anesthesia. It has strong analgesic properties which it shares with morphine. Unlike morphine, it does not possess the ability to bind to the mu3 receptor, and therefore does not have the ability to influence nitric oxide release as measured amperometrically. Cell adhesion also is not influenced. As a result, it also lacks the ability to downregulate the inflammatory response associated with surgery, especially cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687094     DOI: 10.1016/s0167-5273(98)00037-0

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

Review 1.  Anesthetics, immune cells, and immune responses.

Authors:  Shin Kurosawa; Masato Kato
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

Review 2.  The presence of endogenous morphine signaling in animals.

Authors:  George B Stefano; Patrick Cadet; Richard M Kream; Wei Zhu
Journal:  Neurochem Res       Date:  2008-09-06       Impact factor: 3.996

Review 3.  Fentanyl pectin nasal spray: in breakthrough pain in opioid-tolerant adults with cancer.

Authors:  Katherine A Lyseng-Williamson
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

Review 4.  Opioids and matrix metalloproteinases: the influence of morphine on MMP-9 production and cancer progression.

Authors:  Samira Khabbazi; Mohammadhossein Hassanshahi; Alireza Hassanshahi; Yaser Peymanfar; Yu-Wen Su; Cory J Xian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-17       Impact factor: 3.000

Review 5.  Fentanyl sublingual: in breakthrough pain in opioid-tolerant adults with cancer.

Authors:  Claudine M Chwieduk; Kate McKeage
Journal:  Drugs       Date:  2010-12-03       Impact factor: 9.546

Review 6.  Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.

Authors:  R B Muijsers; A J Wagstaff
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Ryan B Gruber; Benjamin Gaston; Tristan H J Lewis; Alan Grossfield; James M Seckler; Yee-Hsee Hsieh; James N Bates; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

Review 8.  Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology.

Authors:  George B Stefano; Richard M Kream; Kirk J Mantione; Melinda Sheehan; Patrick Cadet; Wei Zhu; Thomas V Bilfinger; Tobias Esch
Journal:  Semin Cancer Biol       Date:  2007-12-08       Impact factor: 15.707

9.  Morphine use in cancer surgery.

Authors:  Banafsheh Afsharimani; Peter J Cabot; Marie-Odile Parat
Journal:  Front Pharmacol       Date:  2011-08-08       Impact factor: 5.810

10.  The choice of anaesthetic--sevoflurane or propofol--and outcome from cancer surgery: a retrospective analysis.

Authors:  Mats Enlund; Anders Berglund; Kalle Andreasson; Catharina Cicek; Anna Enlund; Leif Bergkvist
Journal:  Ups J Med Sci       Date:  2014-05-26       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.